ARCHIVES

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

New HIP Analysis Supports Mammography Screening Ages 40-49

September 23, 1988

Philadelphia Group Begins BMT Trial for Breast Cancer

April 5, 1991

NIH Human Connectome Project To Map Brain Connections

July 31, 2009

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

January 3, 2014

Long-Term Estrogen Use May Increase Ovarian Cancer Risk

April 27, 2001

Group Chairmen Accept Most Changes In Terms Of Award, Object To CTEP Adjustments

December 2, 1988